The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Chest Tubes

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Chest Tubes


High impact information on Chest Tubes

  • INTERVENTION: A chest tube was inserted for drainage of the effusion, and pleurodesis was done using bleomycin as the sclerosant [6].
  • In addition, patients taking aspirin or Coumadin required prolonged chest tube drainage compared to those in heparin or control groups (34 +/- 4 versus 20 +/- 1 h) (P less than 0.001) [7].
  • Chest tube drainage measured within the first 35 hr after CABG revealed that the median loss with aspirin daily (965 ml), aspirin three times daily (1175 ml), and aspirin plus dipyridamole (1000 ml) exceeded (p less than .02) that with placebo (805 ml), while median loss with sulfinpyrazone (775 ml) did not [8].
  • A single dose of cisplatin 100 mg/m2 plus cytarabine 1,200 mg was instilled into the pleural space via a chest tube, which was then immediately removed [9].
  • The clopidogrel group had higher 24-h mean chest tube output (1,224 ml vs. 840 ml, p = 0.001), and more transfusions of red blood cells (2.51 U vs. 1.74 U, p = 0.036), platelets (0.86 U vs. 0.24 U, p = 0.001) and fresh frozen plasma (0.68 U vs. 0.24 U, p = 0.015) [10].

Chemical compound and disease context of Chest Tubes


Biological context of Chest Tubes


Anatomical context of Chest Tubes


Associations of Chest Tubes with chemical compounds

  • RESULTS--The response to tetracycline sclerotherapy in the two groups was the same (80%) but the duration of chest tube drainage was significantly shorter for patients in group 2 (median two days) than for those in group 1 (median seven days) [24].
  • The small calibre chest tube with a one way valve is recommended as a safe and easy technique [25].
  • The desmopressin-treated patients in group 2 neither experienced increased mediastinal chest tube drainage nor received increased amounts of homologous blood products when compared to those in group 1.(ABSTRACT TRUNCATED AT 250 WORDS)[26]
  • He responded well to chest-tube drainage and antifungal therapy; he received fluconazole as maintenance therapy for 1 year and has not relapsed [27].
  • All patients had chest tubes inserted on admission, and all were treated with parenteral antibiotics, which included chloramphenicol in 92% of the patients and cloxacillin in 72% [28].

Gene context of Chest Tubes

  • There was a significant difference in duration of chest tube placement between the early and late tPA groups [29].
  • METHODOLOGY: Twelve sheep were divided into three groups and were given a single intrapleural dose of TGF-beta2 (0.25 microg/kg), talc slurry (5 g) or bleomycin (60 IU) via a chest tube [30].
  • There was no association between recurrence rate and COPD/non-COPD, age or duration of chest tube treatment (1-7 days, 8 days or more) [31].
  • Total 8-h chest tube drainage did not correlate with any coagulation test at any time point except with P-selectin expression after protamine administration (r = -0.4; P = 0.03) [32].
  • Mean chest tube duration was 6.3 +/- 0.5 days [33].

Analytical, diagnostic and therapeutic context of Chest Tubes


  1. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Despotis, G.J., Levine, V., Filos, K.S., Santoro, S.A., Joist, J.H., Spitznagel, E., Goodnough, L.T. Anesthesiology (1996) [Pubmed]
  2. Chylothorax: report of a case complicating orthotopic heart transplantation. Bowerman, R.E., Solomon, D.A., Bognolo, D., Brauner, L.R. J. Heart Lung Transplant. (1993) [Pubmed]
  3. Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. Shimizu, K., Yoshida, J., Nishimura, M., Takamochi, K., Nakahara, R., Nagai, K. J. Thorac. Cardiovasc. Surg. (2002) [Pubmed]
  4. Small chest-tube drainage followed by bleomycin sclerosis for malignant pleural effusions. Goff, B.A., Mueller, P.R., Muntz, H.G., Rice, L.W. Obstetrics and gynecology. (1993) [Pubmed]
  5. Subcutaneous seeding after ultrasound-guided placement of intrapleural catheter. An unusual complication of the intracavitary palliative treatment of pleural mesothelioma. Sartori, S., Nielsen, I., Trevisani, L., Tassinari, D., Abbasciano, V. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. (1999) [Pubmed]
  6. Elastance of the pleural space: a predictor for the outcome of pleurodesis in patients with malignant pleural effusion. Lan, R.S., Lo, S.K., Chuang, M.L., Yang, C.T., Tsao, T.C., Lee, C.H. Ann. Intern. Med. (1997) [Pubmed]
  7. Aspirin- and coumadin-related bleeding after coronary- artery bypass graft surgery. Torosian, M., Michelson, E.L., Morganroth, J., MacVaugh, H. Ann. Intern. Med. (1978) [Pubmed]
  8. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Goldman, S., Copeland, J., Moritz, T., Henderson, W., Zadina, K., Ovitt, T., Doherty, J., Read, R., Chesler, E., Sako, Y. Circulation (1988) [Pubmed]
  9. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial. Rusch, V.W., Figlin, R., Godwin, D., Piantadosi, S. J. Clin. Oncol. (1991) [Pubmed]
  10. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. Hongo, R.H., Ley, J., Dick, S.E., Yee, R.R. J. Am. Coll. Cardiol. (2002) [Pubmed]
  11. Thoracoscopic closure of distal bronchopleural fistulas, using tissue glue. Aasebø, U. Eur. Respir. J. (1989) [Pubmed]
  12. Pancreaticopleural fistula: report of two cases and review of the literature. Oh, Y.S., Edmundowicz, S.A., Jonnalagadda, S.S., Azar, R.R. Dig. Dis. Sci. (2006) [Pubmed]
  13. Management of pneumothorax in cystic fibrosis. Schuster, S.R., McLaughlin, F.J., Matthews, W.J., Strieder, D.J., Khaw, K.T., Shwachman, H. J. Pediatr. Surg. (1983) [Pubmed]
  14. Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Dilthey, G., Dietrich, W., Spannagl, M., Richter, J.A. J. Cardiothorac. Vasc. Anesth. (1993) [Pubmed]
  15. Clinical significance of pericardial effusion after heart transplantation. Vandenberg, B.F., Mohanty, P.K., Craddock, K.J., Barnhart, G., Hanrahan, J., Szentpetery, S., Lower, R.R. The Journal of heart transplantation. (1988) [Pubmed]
  16. D-Dimer formation during cardiac and noncardiac thoracic surgery. Whitten, C.W., Greilich, P.E., Ivy, R., Burkhardt, D., Allison, P.M. Anesth. Analg. (1999) [Pubmed]
  17. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Miller, B.E., Tosone, S.R., Tam, V.K., Kanter, K.R., Guzzetta, N.A., Bailey, J.M., Levy, J.H. Ann. Thorac. Surg. (1998) [Pubmed]
  18. Recent improvements in outcome with the Novacor left ventricular assist device. Strauch, J.T., Spielvogel, D., Haldenwang, P.L., Correa, R.K., deAsla, R.A., Seissler, P.E., Baran, D.A., Gass, A.L., Lansman, S.L. J. Heart Lung Transplant. (2003) [Pubmed]
  19. Superior vena cava syndrome as a cause of pleural effusion. Good, J.T., Moore, J.B., Fowler, A.A., Sahn, S.A. Am. Rev. Respir. Dis. (1982) [Pubmed]
  20. Intrapleural alteplase in a patient with complicated pleural effusion. Walker, C.A., Shirk, M.B., Tschampel, M.M., Visconti, J.A. The Annals of pharmacotherapy. (2003) [Pubmed]
  21. Cardiac herniation with catheterization of the heart, inferior vena cava, and hepatic vein by a chest tube. Rashid, M.A., Ackèr, A. The Journal of trauma. (1998) [Pubmed]
  22. Successful treatment with octreotide of spontaneous chylothorax in a premature infant. Coulter, D.M. Journal of perinatology : official journal of the California Perinatal Association. (2004) [Pubmed]
  23. The clinical relevance of hemoglobin, platelet, and serotonin changes in sequestered and circulating blood during cardiopulmonary bypass. McNulty, S.E., Mannion, J., Brennan, M., Schieren, H. J. Cardiothorac. Vasc. Anesth. (1998) [Pubmed]
  24. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Villanueva, A.G., Gray, A.W., Shahian, D.M., Williamson, W.A., Beamis, J.F. Thorax (1994) [Pubmed]
  25. Role of small calibre chest tube drainage for iatrogenic pneumothorax. Laub, M., Milman, N., Müller, D., Struve-Christensen, E. Thorax (1990) [Pubmed]
  26. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Mongan, P.D., Hosking, M.P. Anesthesiology (1992) [Pubmed]
  27. Cryptococcal empyema: case report and review. Mulanovich, V.E., Dismukes, W.E., Markowitz, N. Clin. Infect. Dis. (1995) [Pubmed]
  28. Incidence, management, and outcome of childhood empyema: a prospective study of children in Cambodian refugee camps. Fontanet, A.L., McCauley, R.G., Coyette, Y., Larchiver, F., Bennish, M.L. Am. J. Trop. Med. Hyg. (1993) [Pubmed]
  29. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Weinstein, M., Restrepo, R., Chait, P.G., Connolly, B., Temple, M., Macarthur, C. Pediatrics (2004) [Pubmed]
  30. Comparing transforming growth factor-beta2, talc and bleomycin as pleurodesing agents in sheep. Lee, Y.C., Yasay, J.R., Johnson, J.E., Parker, R.E., Thompson, P.J., Lane, K.B., Light, R.W. Respirology (2002) [Pubmed]
  31. Spontaneous pneumothorax in chronic obstructive pulmonary disease: complications, treatment and recurrences. Videm, V., Pillgram-Larsen, J., Ellingsen, O., Andersen, G., Ovrum, E. European journal of respiratory diseases. (1987) [Pubmed]
  32. Platelet-activated clotting time does not measure platelet reactivity during cardiac surgery. Shore-Lesserson, L., Ammar, T., DePerio, M., Vela-Cantos, F., Fisher, C., Sarier, K. Anesthesiology (1999) [Pubmed]
  33. No-cut thoracoscopic lung plication: a new technique for lung volume reduction surgery. Swanson, S.J., Mentzer, S.J., DeCamp, M.M., Bueno, R., Richards, W.G., Ingenito, E.P., Reilly, J.J., Sugarbaker, D.J. J. Am. Coll. Surg. (1997) [Pubmed]
  34. Modern management of anastomotic leak after esophagogastrectomy. Wilson, S.E., Stone, R., Scully, M., Ozeran, L., Benfield, J.R. Am. J. Surg. (1982) [Pubmed]
  35. Thoracoscopy in acquired immunodeficiency syndrome. Flum, D.R., Steinberg, S.D., Bernik, T.R., Bonfils-Roberts, E., Kramer, M.D., Adams, P.X., Wallack, M.K. J. Thorac. Cardiovasc. Surg. (1997) [Pubmed]
  36. Polybrene neutralization as a means of monitoring heparin therapy for extracoporeal cirulation. Foster, E.D., Spector, J.I., Talarico, L., Umlas, J., Valeri, C.R., Dobnick, D.B., Berger, R.L. Ann. Thorac. Surg. (1977) [Pubmed]
  37. Successful treatment of hepatic hydrothorax with octreotide. Dumortier, J., Leprêtre, J., Scalone, O., Boillot, O., Scoazec, J.Y., Delafosse, B., Chayvialle, J.A. European journal of gastroenterology & hepatology. (2000) [Pubmed]
  38. Assessing energy requirements of patients on respirators. McCamish, M.A., Dean, R.E., Ouellette, T.R. JPEN. Journal of parenteral and enteral nutrition. (1981) [Pubmed]
WikiGenes - Universities